Health Care/Hospital
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026. The Company's presentation, led by Julia Qian, CFO...
2026-04-22 04:00
4263
Veterans still battling with DVA claims system
* Half of younger veterans aged under 50 are avoiding mental health support due to wait times and system complexity * 67% of younger veterans experiencing increased stress or anxiety after trying to access support * Only four in ten (44%) acknowledge the quality and access to veteran suppo...
2026-04-22 03:00
2747
Dimora Medical Goes Viral on TikTok, as Hydrocolloid Roll Finds New Use in Acne Care
NEW YORK, April 21, 2026 /PRNewswire/ -- Over the past 28 days, Dimora Medical
2026-04-22 01:50
3696
Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%
Next-generation, AI-powered Randomization and Trial Supply Management system—designed to get studies to first-patient-in significantly faster CONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ -- Getting a clinical trial from contract to go-live can take months. For sponsors working to deliver thera...
2026-04-21 21:45
3230
Keung To Appointed Official Brand Ambassador for Herbalgy and Touch Cool
KEEP ME UP. HOLD TIGHT. KEEP GOING.
Limited-Edition Collectible Keychains Drop Now
Your Bag, Your Keys, Your Everyday
Download high-resolution images: https://bit.ly/4tw4GyF
2026-04-21 21:30
4147
ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT
An isogenic iPSC and AI-enabled disease modeling platform spanning multiple genetically defined CMT subtypes will be established to support patient stratification, accelerate RTX-117 development, and create a shared foundation for next-generation therapies BRISBANE, Calif., April 21, 2026 /PRNew...
2026-04-21 21:11
2985
Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board (Board). The initiative provides scienti...
2026-04-21 21:05
4839
NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 21, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...
2026-04-21 20:55
4696
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 0.8% while th...
2026-04-21 20:36
2660
HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency to Tackle Global Drug R&D Bottleneck
BOSTON and SUZHOU, China, April 21, 2026 /PRNewswire/ -- HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official launch of theworld's first NHP Hidradenitis Suppurativa (HS) model, based on over ten years of resear...
2026-04-21 20:30
3277
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study PHILADELPHIA and MELBOURNE, Australia, April 21, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety t...
2026-04-21 20:00
2857
Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)
* Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) * Findings emphasize clinical decision-making in long-term management of inflammatory bo...
2026-04-21 20:00
4446
OUE REIT Delivers Higher Revenue and NPI in 1Q 2026
Driven by Resilient Commercial Performance and Double-Digit Hospitality Growth * Revenue and Net Property Income ("NPI") rose 6.7% and 8.4% year-on-year ("YoY") respectively in 1Q 2026 * Finance costs declined significantly by 17.8% YoY * Maiden foray into Australia with acquisition of a 19....
2026-04-21 18:09
4809
From Molecular Design to Scalable Execution: The Combined Impact of AI and Flow Chemistry
SHANGHAI, April 21, 2026 /PRNewswire/ -- As drug discovery places greater emphasis on practical execution and scalable delivery, flow chemistry is playing an increasingly important role across modern synthesis workflows. At the latest Viva Biotech's series webinar, "AI x Flow Chemistry: From Benc...
2026-04-21 17:57
3946
Calbee Brings Body Granola to Singapore
* Body Granola combines a gut health test with a personalized granola subscription * Used by over 50,000 people, the Singapore launch marks the service's first step beyond Japan TOKYO, April 21, 2026 /PRNewswire/ -- Calbee, Inc. ("Calbee") announced today that it will bringBody Granola to Sin...
2026-04-21 13:00
2988
Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026
HONG KONG, April 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that positive Phase II results from the COMPASSION-26 study evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, in combination with chemotherapy as first-line treatme...
2026-04-21 10:54
3590
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
– RECIST-based ORR of 38.5% (confirmed) and 46.2% (unconfirmed) – mRECIST-based ORR of 61.5% with a complete response (CR) rate of 23% – No Grade 3 or higher adverse events related to RZ-001 observed – Highlights clinical potential of RNA trans-splicing ribozyme platform technology SEOUL, South...
2026-04-21 10:10
3033
Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time
SHANGHAI, April 21, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, has successfully passed the on-site GMP inspection conducted by the Jordan Food and Drug Adminis...
2026-04-21 10:00
4459
Joint Commission International Launches Global Patient Safety Awards to Recognize Innovative Healthcare Practices and Excellence
Nominations open for healthcare organizations, national health authorities around the world that demonstrate improvements in safe, quality patient care OAKBROOK TERRACE, Ill., April 21, 2026 /PRNewswire/ -- Joint Commission International (JCI) today launched the nomination process for its inaugur...
2026-04-21 10:00
2879
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
SAN DIEGO, April 20, 2026 /PRNewswire/ -- Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ABO2203 in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). The data we...
2026-04-20 22:00
3863
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 280 media titles]
2026-05-20 09:15Most Read
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
6049
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
6044
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
5933
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
5886
